Literature DB >> 3611299

Age-dependent antibody response in mice and humans following oral influenza immunization.

R H Waldman, K C Bergmann, J Stone, S Howard, V Chiodo, A Jacknowitz, E R Waldman, R Khakoo.   

Abstract

In order to compare the antibody response in serum and secretions from healthy young subjects and the elderly (greater than 60 years), volunteers were immunized with the commercial inactivated influenza virus vaccine, by the usual (parenteral) route or orally. Also, young and old mice (mean age, 20 months) were orally immunized with live influenza virus. The older mice responded with a very slight rise in their serum and respiratory tract antibody levels compared with the young mice but showed no diminution in protection against lethal viral challenge. Elderly volunteers showed only slight serum antibody responses after parenteral immunization compared with the young. Neither group demonstrated a rise in serum antibody following oral immunization. With respect to the secretory IgA (SIgA) antibody response, certain differences were noted between the young and the elderly: the preimmunization levels of antibody to influenza virus were significantly greater in nasal secretions and saliva in the elderly as compared to the young volunteers, and the salivary antibody response was diminished in the elderly. This lack of a salivary antibody response in the elderly was explicable by the inverse relationship between the preimmunization SIgA antibody titers and the response to immunization. Oral immunization led to no more side effects than observed in the placebo control group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611299     DOI: 10.1007/bf00915555

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  Bronchial lymphoid tissue. I. Morphologic characteristics.

Authors:  J Bienenstock; N Johnston; D Y Perey
Journal:  Lab Invest       Date:  1973-06       Impact factor: 5.662

2.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

3.  The role of nasal secretion and serum antibody in the rhinovirus common cold.

Authors:  T R Cate; R D Rossen; R G Douglas; W T Butler; R B Couch
Journal:  Am J Epidemiol       Date:  1966-09       Impact factor: 4.897

4.  Influenza vaccines 1982-1983.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-07-09       Impact factor: 17.586

5.  The lectin neuraminidase inhibition test: a new method for the detection of antibodies to neuraminidase.

Authors:  P Luther; G E Klett; S Weber; H Pechmann; K C Bergmann
Journal:  J Biol Stand       Date:  1983-04

6.  Salivary and serum IgA levels in a geriatric outpatient population.

Authors:  M S Finkelstein; M Tanner; M L Freedman
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

7.  Induction of secretory antibodies in humans following ingestion of Streptococcus mutans.

Authors:  J R McGhee; J Mestecky; R R Arnold; S M Michalek; S J Prince; J L Babb
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

8.  Effective immunity to dental caries: selective induction of secretory immunity by oral administration of Streptococcus mutans in rodents.

Authors:  S M Michalek; J R McGhee; R R Arnold; J Mestecky
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

9.  Antibodies against influenza and stimulated macrophages in the lung lavage fluid of mice following oral immunization.

Authors:  K C Bergmann; R H Waldman
Journal:  Allerg Immunol (Leipz)       Date:  1983

10.  Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine.

Authors:  R L Clancy; A W Cripps; A J Husband; D Buckley
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more
  9 in total

Review 1.  Impact of aging on gastrointestinal mucosal immunity.

Authors:  D L Schmucker; M F Heyworth; R L Owen; C K Daniels
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 2.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 3.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 4.  Mucosal vaccines for the prevention of influenza.

Authors:  R L Clancy
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

5.  Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.

Authors:  D C Powers; S D Sears; B R Murphy; B Thumar; M L Clements
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

Review 6.  Microneedle and mucosal delivery of influenza vaccines.

Authors:  Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim
Journal:  Expert Rev Vaccines       Date:  2012-05       Impact factor: 5.217

Review 7.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens.

Authors:  N Santiago; S Milstein; T Rivera; E Garcia; T Zaidi; H Hong; D Bucher
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

9.  Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.